Revel Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Revel Pharmaceuticals's estimated annual revenue is currently $697.5k per year.
- Revel Pharmaceuticals's estimated revenue per employee is $77,500
Employee Data
- Revel Pharmaceuticals has 9 Employees.
- Revel Pharmaceuticals grew their employee count by 80% last year.
Revel Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Head Enzyme Engineering | Reveal Email/Phone |
3 | Research Associate II | Reveal Email/Phone |
4 | Research Associate II | Reveal Email/Phone |
5 | Scientist II | Reveal Email/Phone |
Revel Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Revel Pharmaceuticals?
Revel Pharmaceuticals is a biotechnology commercializing therapeutic enzymes to degrade age associated molecule damage. We are targeting pathological age associated compounds known as Advanced Glycation End Products (AGEs) which build up on long lived proteins like collagen. AGE accumulation is implicated in multiple diseases of aging, thus Revel Pharmaceuticals is strategically position to develop therapeutics across multiple indications.
keywords:N/AN/A
Total Funding
9
Number of Employees
$697.5k
Revenue (est)
80%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.2M | 9 | 0% | $24.7M |
#2 | $0.1M | 9 | -36% | N/A |
#3 | $7.5M | 9 | -18% | N/A |
#4 | $0.7M | 9 | N/A | N/A |
#5 | $0.1M | 9 | -25% | N/A |